A magnetic resonance imaging study to assess the short-term physical modifications of the disease process after SB-061 treatment

Trial Profile

A magnetic resonance imaging study to assess the short-term physical modifications of the disease process after SB-061 treatment

Planning
Phase of Trial: Phase II

Latest Information Update: 27 Aug 2017

At a glance

  • Drugs SB 061 (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms MODIFY-MRI
  • Most Recent Events

    • 27 Aug 2017 New trial record
    • 23 Aug 2017 According to a SYMIC Biomedical media release, the company expects to report top-line results from the study in early 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top